β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation

I Ahmad,J P Morton,L B Singh,S M Radulescu,R A Ridgway,S Patel,J Woodgett,D J Winton,M M Taketo,X-R Wu,H Y Leung,O J Sansom
DOI: https://doi.org/10.1038/onc.2010.399
IF: 8.756
2010-09-06
Oncogene
Abstract:Although deregulation of the Wnt signalling pathway has been implicated in urothelial cell carcinoma (UCC), the functional significance is unknown. To test its importance, we have targeted expression of an activated form of β-catenin to the urothelium of transgenic mice using Cre–Lox technology (UroIICRE+β-cateninexon3/+). Expression of this activated form of β-catenin led to the formation of localized hyperproliferative lesions by 3 months, which did not progress to malignancy. These lesions were characterized by a marked increase of the phosphatase and tensin homologue (PTEN) tumour suppressor protein. This appears to be a direct consequence of activating Wnt signalling in the bladder as conditional deletion of the adenomatous polyposis coli (Apc) gene within the adult bladder led rapidly to coincident β-catenin and PTEN expression. This PTEN expression blocked proliferation. Next, we combined PTEN deficiency with β-catenin activation and found that this caused papillary UCC. These tumours had increased pAKT signalling and were dependent on mammalian target of rapamycin (mTOR). Importantly, in human UCC, there was a significant correlation between high levels of β-catenin and pAKT (and low levels of PTEN). Taken together these data show that deregulated Wnt signalling has a critical role in promoting UCC, and suggests that human UCC that have high levels of Wnt and PI3 kinase signalling may be responsive to mTOR inhibition.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the synergistic effect of abnormal activation of the Wnt signaling pathway and loss of the PTEN tumor - suppressor gene in the occurrence of bladder cancer. Specifically, through transgenic mouse models, the researchers verified that activation of β - catenin alone is not sufficient to trigger bladder cancer, but when combined with PTEN gene deletion, it can significantly promote the development of urothelial carcinoma of the bladder (UCC). This study not only reveals the important roles of the Wnt signaling pathway and PTEN in the occurrence of bladder cancer, but also provides experimental evidence for understanding the correlation between these two molecular alterations in human bladder cancer. ### Main research questions: 1. **Is abnormal activation of the Wnt signaling pathway sufficient to trigger bladder cancer?** - Research results show that activation of β - catenin (a key protein in the Wnt signaling pathway) alone can only lead to benign hyperplasia of the bladder epithelium and cannot progress to malignant tumors. 2. **What is the impact of PTEN gene loss on abnormal activation of the Wnt signaling pathway?** - When β - catenin activation and PTEN gene loss co - exist, they can significantly promote the occurrence and development of urothelial carcinoma of the bladder. 3. **What is the correlation between abnormal activation of the Wnt signaling pathway and PTEN gene loss in human bladder cancer?** - By analyzing human bladder cancer tissue samples, a significant correlation was found between activation of the Wnt signaling pathway (manifested as up - regulation of nuclear β - catenin) and decreased PTEN expression as well as up - regulation of pAKT. ### Experimental design and results: - **Transgenic mouse model**: Use the Cre - Lox technique to specifically express the activated form of β - catenin in the bladder epithelium and observe its impact on the bladder epithelium. - Activation of β - catenin alone leads to benign hyperplasia of the bladder epithelium but does not develop into a malignant tumor. - After β - catenin activation, PTEN expression increases significantly, inhibiting cell proliferation. - Combining PTEN gene deletion and β - catenin activation, mice rapidly develop urothelial carcinoma of the bladder, and the tumors show activation of the mTOR signaling pathway. - **Analysis of human bladder cancer samples**: Through the analysis of 80 human bladder cancer tissue samples, a significant correlation was found between up - regulation of nuclear β - catenin and decreased PTEN expression as well as up - regulation of pAKT. ### Conclusions: - Abnormal activation of the Wnt signaling pathway alone is not sufficient to trigger bladder cancer, but when it acts synergistically with PTEN gene loss, it can significantly promote the occurrence and development of urothelial carcinoma of the bladder. - Activation of the Wnt signaling pathway and loss of PTEN in human bladder cancer may be an important carcinogenic mechanism, suggesting that these patients may be sensitive to mTOR inhibitors. This study provides new insights into the pathogenesis of bladder cancer and potential targets for future treatment strategies.